Neurodegenerative Drug Development Summit

Description

CureDuchenne at the Neuromuscular Drug Development Summit 2020

This key industry meeting is returning for its 3rd year as a digital forum so this community can come together despite the restrictions imposed on us by the coronavirus pandemic. 

With the ambitious goal of accelerating the discovery and development of meaningful treatments for patients suffering from neuromuscular disease, here’s what you stand to gain from attending: 

• Gain an important market update on approaches to optimizing therapeutic efficacy in Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Amyotrophic Lateral Sclerosis and other rare diseases 
• Engage in critical discussions with industry and academic experts to discuss how to demonstrate a clear mechanistic route between dose, mechanisms of action and endpoints 
• Establish lasting connections within this niche community through dedicated virtual networking sessions to kickstart valuable collaborations